These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38478015)

  • 1. m 6 A reader IGF2BP1 reduces the sensitivity of nasopharyngeal carcinoma cells to Taxol by upregulation of AKT2.
    Zhao C; Zhang F; Tian Y; Tang B; Luo J; Zhang J
    Anticancer Drugs; 2024 Jul; 35(6):501-511. PubMed ID: 38478015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes derived from Taxol-resistant nasopharyngeal carcinoma (NPC) cells transferred DDX53 to NPC cells and promoted cancer resistance to Taxol.
    Yuan F; Zhou ZF
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):127-138. PubMed ID: 33506900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triptonide inhibits human nasopharyngeal carcinoma cell growth via disrupting Lnc-RNA THOR-IGF2BP1 signaling.
    Wang SS; Lv Y; Xu XC; Zuo Y; Song Y; Wu GP; Lu PH; Zhang ZQ; Chen MB
    Cancer Lett; 2019 Feb; 443():13-24. PubMed ID: 30503558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing Op18/stathmin by RNA Interference Promotes the Sensitivity of Nasopharyngeal Carcinoma Cells to Taxol and High-Grade Differentiation of Xenografted Tumours in Nude Mice.
    Lin X; Yu T; Zhang L; Chen S; Chen X; Liao Y; Long D; Shen F
    Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):611-620. PubMed ID: 27289016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neferine sensitized Taxol-resistant nasopharygeal carcinoma to Taxol by inhibiting EMT via downregulating miR-130b-5p.
    Wang X; Wang K; Xiao J; Song Y; Li H
    Biochem Biophys Res Commun; 2020 Oct; 531(4):573-580. PubMed ID: 32811645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosome-Mediated Transfer of ALDH2 in Nasopharyngeal Carcinoma Cells Confers Increased Resistance to Paclitaxel Treatment.
    Yan J; Wu L; Zheng M; Pan F
    Discov Med; 2024 Jun; 36(185):1210-1220. PubMed ID: 38926107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXD3 inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma through regulation of the PI3K-Akt pathway.
    Xie X; Xiong G; Chen W; Fu H; Li M; Cui X
    Biochem Cell Biol; 2020 Dec; 98(6):653-660. PubMed ID: 32459973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taxol-Resistant Gene 1 (Txr1) Mediates Oxaliplatin Resistance by Inducing Autophagy in Human Nasopharyngeal Carcinoma Cells.
    Chi HM; Du JD; Cheng J; Mao HD
    Med Sci Monit; 2019 Jan; 25():475-483. PubMed ID: 30650069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
    Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
    FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR‑182‑5p contributes to radioresistance in nasopharyngeal carcinoma by regulating BNIP3 expression.
    He W; Jin H; Liu Q; Sun Q
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MircoRNA-629 promotes proliferation, invasion and migration of nasopharyngeal carcinoma through targeting PDCD4.
    Zheng YQ; Bai YF; Yang S; Cui YR; Wang YP; Hu WL
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):207-216. PubMed ID: 30657562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role and molecular mechanism of NOP16 in the pathogenesis of nasopharyngeal carcinoma.
    Xiong W; Li D; Ao F; Tu Z; Xiong J
    Cell Biochem Funct; 2024 Mar; 42(2):e3939. PubMed ID: 38454810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic methylation profiling combined with gene expression microarray reveals the aberrant methylation mechanism involved in nasopharyngeal carcinoma taxol resistance.
    Zhang X; Li W; Li H; Ma Y; He G; Tan G
    Anticancer Drugs; 2012 Sep; 23(8):856-64. PubMed ID: 22824824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-634 sensitizes nasopharyngeal carcinoma cells to paclitaxel and inhibits cell growth both in vitro and in vivo.
    Peng X; Cao P; He D; Han S; Zhou J; Tan G; Li W; Yu F; Yu J; Li Z; Cao K
    Int J Clin Exp Pathol; 2014; 7(10):6784-91. PubMed ID: 25400759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of chromosome 8q21-qter associated with the acquired paclitaxel resistance of nasopharyngeal carcinoma cells.
    Li W; You Y; Zhang X; Song Y; Xiang H; Peng X; Qin J; Tan G
    Int J Clin Exp Pathol; 2015; 8(10):12346-56. PubMed ID: 26722421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of AKR1C1 is a good prognostic factor in advanced NPC cases and increases chemosensitivity to cisplatin in NPC cells.
    Zhou C; Shen G; Yang F; Duan J; Wu Z; Yang M; Liu Y; Du X; Zhang X; Xiao S
    J Cell Mol Med; 2020 Jun; 24(11):6438-6447. PubMed ID: 32307891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jervine exhibits anticancer effects on nasopharyngeal carcinoma through promoting autophagic apoptosis via the blockage of Hedgehog signaling.
    Chen J; Wen B; Wang Y; Wu S; Zhang X; Gu Y; Wang Z; Wang J; Zhang W; Yong J
    Biomed Pharmacother; 2020 Dec; 132():110898. PubMed ID: 33113432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-331-3p Inhibits Proliferation and Promotes Apoptosis of Nasopharyngeal Carcinoma Cells by Targeting elf4B-PI3K-AKT Pathway.
    Xuefang Z; Ruinian Z; Liji J; Chun Z; Qiaolan Z; Jun J; Yuming C; Junrong H
    Technol Cancer Res Treat; 2020; 19():1533033819892251. PubMed ID: 31984860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL14 contributes to the progression of nasopharyngeal carcinoma through regulating the stability of AOC1 mRNA.
    Hu C; Song S; Zhao S; Xue Z; Zhu X
    Hereditas; 2024 Jul; 161(1):20. PubMed ID: 38956710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of Insulin-Like Growth Factor-1 Receptor (IGF-1R) Reverses the Inhibitory Effect of Let-7g-5p on Migration and Invasion of Nasopharyngeal Carcinoma.
    Zhao Z; Wen J; Peng L; Liu H
    Med Sci Monit; 2019 Aug; 25():5747-5756. PubMed ID: 31374070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.